Lombard Odier Asset Management (Europe)’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-2,210
| Closed | -$338K | – | 259 |
|
|
2021
Q1 | $338K | Buy |
+2,210
| New | +$338K | 0.02% | 155 |
|
|
2020
Q4 | – | Sell |
-1,753
| Closed | -$201K | – | 409 |
|
|
2020
Q3 | $201K | Buy |
+1,753
| New | +$201K | 0.01% | 338 |
|
|
2020
Q2 | – | Sell |
-2,462
| Closed | -$221K | – | 294 |
|
|
2020
Q1 | $221K | Hold |
2,462
| – | – | 0.02% | 253 |
|
|
2019
Q4 | $266K | Hold |
2,462
| – | – | 0.02% | 314 |
|
|
2019
Q3 | $241K | Hold |
2,462
| – | – | 0.02% | 328 |
|
|
2019
Q2 | $322K | Hold |
2,462
| – | – | 0.03% | 260 |
|
|
2019
Q1 | $333K | Hold |
2,462
| – | – | 0.03% | 232 |
|
|
2018
Q4 | $240K | Hold |
2,462
| – | – | 0.02% | 283 |
|
|
2018
Q3 | $342K | Buy |
2,462
+243
| +11% | +$33.8K | 0.02% | 247 |
|
|
2018
Q2 | $275K | Hold |
2,219
| – | – | 0.02% | 268 |
|
|
2018
Q1 | $247K | Sell |
2,219
-225
| -9% | -$25K | 0.02% | 295 |
|
|
2017
Q4 | $292K | Sell |
2,444
-350
| -13% | -$41.8K | 0.02% | 281 |
|
|
2017
Q3 | $392K | Hold |
2,794
| – | – | 0.02% | 248 |
|
|
2017
Q2 | $340K | Hold |
2,794
| – | – | 0.02% | 265 |
|
|
2017
Q1 | $339K | Hold |
2,794
| – | – | 0.02% | 262 |
|
|
2016
Q4 | $342K | Hold |
2,794
| – | – | 0.12% | 219 |
|
|
2016
Q3 | $342K | Hold |
2,794
| – | – | 0.12% | 235 |
|
|
2016
Q2 | $326K | Buy |
+2,794
| New | +$326K | 0.02% | 266 |
|